Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells ; volume:15 ; number:1 ; day:19 ; month:10 ; year:2023 ; pages:1-16 ; date:12.2023
Clinical epigenetics ; 15, Heft 1 (19.10.2023), 1-16, 12.2023
- Urheber
-
O’Brien, Eleanor
Tse, Carmen
Tracy, Ian
Reddin, Ian
Selfe, Joanna
Gibson, Jane
Tapper, William
Pengelly, Reuben J.
Gao, Jinhui
Aladowicz, Ewa
Petts, Gemma
Thway, Khin
Popov, Sergey
Kelsey, Anna
Underwood, Timothy J.
Shipley, Janet
Walters, Zoë S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-023-01583-w
- URN
-
urn:nbn:de:101:1-2024020908060234659654
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- O’Brien, Eleanor
- Tse, Carmen
- Tracy, Ian
- Reddin, Ian
- Selfe, Joanna
- Gibson, Jane
- Tapper, William
- Pengelly, Reuben J.
- Gao, Jinhui
- Aladowicz, Ewa
- Petts, Gemma
- Thway, Khin
- Popov, Sergey
- Kelsey, Anna
- Underwood, Timothy J.
- Shipley, Janet
- Walters, Zoë S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma
Lineage of origin in rhabdomyosarcoma informs pharmacological response
Pharmacological inhibition of EZH2 disrupts the female germline epigenome
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoic X receptor activation
Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma
Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection
Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma
Lineage of origin in rhabdomyosarcoma informs pharmacological response
Pharmacological inhibition of EZH2 disrupts the female germline epigenome
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoic X receptor activation
Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma
Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection
Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma
Lineage of origin in rhabdomyosarcoma informs pharmacological response
Pharmacological inhibition of EZH2 disrupts the female germline epigenome
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoic X receptor activation
Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma
Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection
Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription
FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells